资讯

PMLive12 分钟
MHRA approves Accord Healthcare’s Hetronifly to treat aggressive form of lung cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...
Theravance Biopharma Announces Approval Of YUPELRI® (Revefenacin) By China's NMPA
YUPELRI approved by China's NMPA as the first once-daily nebulized LAMA for maintenance treatment of COPD <li /> Approval triggers ...